Keya Bandyopadhyay

Title: Keya Bandyopadhyay: Innovator in Cancer Research

Introduction

Keya Bandyopadhyay is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer research. With a focus on developing innovative methods and compositions for tumor suppression, she has been awarded 3 patents for her groundbreaking work.

Latest Patents

Her latest patents include "Methods and compositions for topoisomerase I modulated tumor suppression," which discloses methods for determining and enhancing the sensitivity of cells to topoisomerase I inhibitors. This patent also covers methods for inducing cell death, apoptosis, and growth arrest, which may be utilized for tumor suppression. Another notable patent is "Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism." This patent outlines a method for treating cancer by administering a specific compound to subjects in need, thereby improving treatment outcomes.

Career Highlights

Throughout her career, Keya has worked with various organizations, including Rg Biopharma LLC and Vanderbilt University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.

Collaborations

Keya has collaborated with notable colleagues such as Ruth Anne Gjerset and Joseph Parello, further enhancing her research and development efforts in cancer therapies.

Conclusion

Keya Bandyopadhyay's innovative work in cancer research exemplifies her dedication to improving treatment options for patients. Her patents and collaborations highlight her significant impact on the field, making her a key figure in the ongoing fight against cancer.